Skip to main content


Fig. 5 | Diabetology & Metabolic Syndrome

Fig. 5

From: Degludec: the new ultra-long insulin analogue

Fig. 5

The frequency of confirmed nocturnal hypoglycemia (between 00:01 and 5:59 am) with insulin degludec (IDeg) and comparators (insulin glargin, except in trial 3580 [sitagliptin]) in Type 2 diabetes patients participating in 6 therapeutic confirmatory trials. FF: Fixed-flexible schedule; PYE: patient years of exposure; T1D: Type 1 diabetes; T2D: Type 2 diabetes. Adapted from Reference [15]

Back to article page